
SyntheticGestalt (Shinjuku, Tokyo; CEO Koki Shimada; hereinafter "our company") is pleased to announce its selection for the "J-StarX AI Medical Course" program implemented by the Ministry of Economy, Trade and Industry (METI) and the Japan External Trade Organization (JETRO). This highly competitive program selects a maximum of 12 companies through rigorous selection processes, and our company was chosen based on the recognition of our technological capabilities and growth potential with the world's largest molecular-specialized foundation AI model.
Program Overview and Support Details
The "J-StarX AI Medical Course" is a public-private partnership program supporting Japanese healthtech startups' entry into the US market. Participating companies receive the following comprehensive support:
- Specialized lectures on the US healthcare ecosystem and regulations
- Visits to Mayo Clinic, one of the world's largest medical institutions, and collaboration opportunities
- Support for market entry strategy development
- Networking opportunities with local ecosystem stakeholders
Our Initiatives and Prospects
Through participation in this program, our company aims to establish a business foundation in the US market and expand our network. Specifically, we will leverage our world's largest molecular-specialized foundation AI model "SG4D10B" to provide innovative solutions in the AI drug discovery field through collaboration with local pharmaceutical companies.
Daisuke Morohashi, Head of AI Business Division, commented: "Our selection reflects the high recognition of the innovation and growth potential of our molecular-specialized AI technology. Through J-StarX's support, we will expand Japanese-originated AI technology throughout the United States and contribute to revolutionary advances in biological science research."
About SyntheticGestalt
SyntheticGestalt develops AI technology specialized in molecular information. In 2024 and 2025, we unveiled the world's largest molecule-specific foundation model at NVIDIA GTC (one of the world's largest AI conferences). Our molecular foundation model resolves accuracy challenges faced by conventional molecular AI. We aim to apply this technology across various fields including pharmaceuticals, cosmetics, agrochemicals, and new materials. Our mission is to contribute to the advancement of civilization through AI-driven innovations.
Contact Information
Contact: PR Representative, Naoki Furuya
TEL: 03-4570-8634
Email: info@syntheticgestalt.com
[For Media Interviews and Technical Inquiries]
Contact: Head of AI Business Division, Daisuke Morohashi
Email: d.morohashi@syntheticgestalt.com
